>
Switch to:

Turning Point Therapeutics Current Ratio

: 46.35 (As of Dec. 2020)
View and export this data going back to 2019. Start your Free Trial

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Turning Point Therapeutics's current ratio for the quarter that ended in Dec. 2020 was 46.35.

Turning Point Therapeutics has a current ratio of 46.35. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

NAS:TPTX' s Current Ratio Range Over the Past 10 Years
Min: 10.08   Med: 24.33   Max: 46.35
Current: 46.35

10.08
46.35

During the past 4 years, Turning Point Therapeutics's highest Current Ratio was 46.35. The lowest was 10.08. And the median was 24.33.

NAS:TPTX's Current Ratio is ranked higher than
98% of the 1360 Companies
in the Biotechnology industry.

( Industry Median: 4.96 vs. NAS:TPTX: 46.35 )

Turning Point Therapeutics Current Ratio Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

* Premium members only.

Turning Point Therapeutics Annual Data
Dec17 Dec18 Dec19 Dec20
Current Ratio 10.08 19.08 29.57 46.35

Turning Point Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Current Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.57 34.91 62.79 35.45 46.35

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Turning Point Therapeutics Current Ratio Distribution

* The bar in red indicates where Turning Point Therapeutics's Current Ratio falls into.



Turning Point Therapeutics Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Turning Point Therapeutics's Current Ratio for the fiscal year that ended in Dec. 2020

Current Ratio (A: Dec. 2020 )=Total Current Assets (A: Dec. 2020 )/Total Current Liabilities (A: Dec. 2020 )
=1130.679/24.392
=46.35

Turning Point Therapeutics's Current Ratio for the quarter that ended in Dec. 2020 is calculated as

Current Ratio (Q: Dec. 2020 )=Total Current Assets (Q: Dec. 2020 )/Total Current Liabilities (Q: Dec. 2020 )
=1130.679/24.392
=46.35

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.


Turning Point Therapeutics  (NAS:TPTX) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Turning Point Therapeutics Current Ratio Related Terms


Turning Point Therapeutics Current Ratio Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)